Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 183

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 183
---
. 107, 9000 St. Gallen, Switzerland. You can participate in the NLS Meeting, vote and submit questions in person. Purpose of the NLS Meeting NLS and Kadimastem have entered into a Merger Agreement. In order to give effect to the Merger Agreement, NLS must fulfill various closing conditions. The compliance with certain closing conditions can only be effected by resolutions of the shareholders’ meeting, as these conditions are within the competence of the shareholders’ meeting. The Merger Agreement requires the NLS Meeting to approve the following resolutions: •Proposal No. 1 to approve the Merger Agreement. •Proposal No. 2 to approve the ordinary share capital increase with contribution of the Kadimastem shares to implement the Merger. •Proposal No. 4 to approve the reinstatement of the capital band. •Proposal No. 6 to approve the conditional share capital for shareholders’ options. •Proposal No. 9 to approve the election of the new members to the NLS Board. •Proposal No. 13 to approve the CVR Agreement. •Proposal No. 14 to approve the conversion of outstanding options and RSUs issued by Kadimastem. Further agenda items are: •Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of preferred shares. •Proposal No. 5 to approve the conditional share capital for employee and advisory options. •Proposal No. 7 to approve the transfer and voting rights limitation of 9.99%. •Proposal No. 8 to approve the name change of NLS. •Proposal No. 10 to approve the election of members of the Compensation, Nomination and Governance Committee. •Proposal No. 11 to approve the composition of the new senior management following the Merger. •Proposal No. 12.1 to approve the compensation for the members of the NLS Board. •Proposal No. 12.2 to approve compensation for the executive officers. Recommendation of the NLS Board The NLS Board has unanimously determined that the each of the Proposals is fair to and in the best interests of NLS and its shareholders; has unanimously approved each of the Proposals; and unanimously recommends that shareholders vote “FOR” each of the Proposals. 74 Record Date; Outstanding Shares; Shareholders Entitled to Vote As of the date of this proxy statement/prospectus, NLS has a share capital of CHF 187,374.51, divided into 4,708,002